Arcus Biosciences stock plunged Friday, reversing a nearly 300% gain, after its Gilead Sciences-partnered cancer regimen ...

Need a walk-in tub in Minnesota? Our top picks include Ella's Bubbles, Kohler and Independent Home. Compare features, costs, reviews and more.

Arcus ends its Phase 3 STAR-221 trial after a futility review and shifts R&D toward casdatifan, supported by strong early RCC ...

Significant unmet needs among people with RA-ILD have been identified in a recent survey, with clear gaps in the services ...

Learn how aging affects your hands and get expert tips to maintain hand health, manage age-related conditions, and prevent ...

Gastroenterologist Dr. Saurabh Sethi highlights that early health changes are often missed due to our fast-paced lives. He urges attention to subtle body signals like brain fog, post-meal fatigue, and ...

Roivant (NASDAQ: ROIV) outlined accelerated timelines and expanded commercial ambitions for several late-stage programs.

Roivant enters new phase of corporate journey with 3+ launches, 4+ NDA/BLA filings, 8+ pivotal and 3+ proof-of-concept study readouts expected ...

Although many people think of osteoarthritis as only a joint problem, new research shows it might be linked to other serious ...

A woman will be the first person in the UK to trial new 3D imaging technology designed to give earlier diagnosis of diseases ...

Nerandomilast is an oral, preferential PDE4B inhibitor approved in China for the treatment of adult patients with IPF and PPF. It was also approved by the U.S. Food and Drug Administration (FDA) for ...